Combined oral contraceptives and liver cancer
โ Scribed by Ramiro Molina; Luis Martinez; Oriana Salas; Aifredo Dabancens; Tao Yun; Chen Zhi-Heng; Hu Yong-Wei; Alvaro Cuadros; Nubia Aristizabal; Baruch Modan; Elaine Ron; Esther Alfandary; J. G. Mati; Patrick Kenya; Alfred Kungu; D. Gatei; Patrick A. Ibeziako; A. A. Abioye; T. A. Junaid; Patrick U. Aghadiuno; Ruben A. Apelo; Julietta R. De LaCruz; Jose Baens; Benjamin D. Canlas JR.; Suporn Silpisornkosol; Tieng Pardthaisong; Boonlong Sivasomboom; Choti Theetranont; Banpot Boosiri; Supawat Chutivongse; Pramuan Virutamasen; Chansuda Wongsrichanalai; Sermsri Sindhvananda; Suporn Koetsawang; Duangdao Rachawat; Orawan Kiriwat; Nivat Chantarakul; P. P. Anthony; David B. Thomas; Janet L. Stanford; Roberta M. Ray; Elizabeth A. Noonan; Susan Holck
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 644 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
THE WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES
The data collection centers and the principal investigator (PI), co-investigator (CI), and pathologist (P) at each center, in alphabetical order by country, are as follows:
๐ SIMILAR VOLUMES
A national population-based case-control study was conducted in New Zealand to assess the effects of hormonal contraception on breast-cancer risk. A total of 891 Women aged 25 to 54 with a first diagnosis of breast cancer, and 1864 control subjects, randomly selected from the electoral rolls, were i
One hundred and seventy four (81% of all) pathologically confirmed new incident cases of female breast cancer identified from a medical center in Taipei from February, 1993 to June, 1994 were selected as the case group. Four hundred and fifty three inpatient controls who were without obstetricgyneco